Drug intelligence / Profile preview

Tetrabik

Development stage
Discontinued
Lead developer
Research Foundation for Microbial Diseases of Osaka University
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

**Tetrabik** is a Japanese pediatric quadrivalent combination vaccine originally developed under the code **BK-4SP**. It contains adsorbed diphtheria and tetanus toxoids, purified pertussis antigens, and inactivated poliovirus derived from Sabin strains, and is administered subcutaneously to induce active humoral immunity against pertussis, diphtheria, tetanus, and poliomyelitis. The product was manufactured by BIKEN and marketed by Mitsubishi Tanabe Pharma in Japan. ([id-info.jihs.go.jp](https://id-info.jihs.go.jp/niid/ja/polio-m/polio-iasrd/9238-477d01.html))

Brand names
Tetrabikテトラビック皮下注シリンジ
Other names
adsorbed diphtheria-purified pertussis-tetanus-inactivated polio vaccineDPT-sIPV vaccine
02

Targets

Poliovirus type 3 capsid D-antigenPoliovirus type 1 capsid D-antigenDiphtheria toxinFHA (Filamentous hemagglutinin)Poliovirus type 2 capsid protein

Beyond the preview

Go deeper on Tetrabik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetrabik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call